Literature DB >> 9766435

Induction of growth inhibition of 293 cells by downregulation of the cyclin E and cyclin-dependent kinase 4 proteins due to overexpression of TIS21.

I K Lim1, M S Lee, M S Ryu, T J Park, H Fujiki, H Eguchi, W K Paik.   

Abstract

We earlier reported that TIS21 mRNA expression was markedly decreased in A549 and NCIH69 human lung cancer cells and in thymic carcinoma tissues obtained from transgenic mice containing simian virus 40 large T antigen (J Cancer Res Clin Oncol 121:279-284, 1995). To determine how TIS21 inhibits growth, we made 293 cells that constitutively expressed TIS21 protein. The constitutive TIS21 expresser lines C9 and C11 grew to a lower saturation density than did those in the vector-transfected clones (V7 and V10) and antisense-transfected clones (AS1 and AS4), and the size of the C9 and C11 cells increased significantly after transfection with TIS21 cDNA. The serum-stimulated cell cycle was analyzed by fluorescence-activated cell sorting after double thymidine treatment; V10 progressed normally through the cell division cycle, but C9 and C11 cells accumulated continuously in G1 phase until 36 h after treatment. On the other hand, the progression of cells that had already entered to S or G2/M phase was not inhibited. When cell-cycle regulatory proteins were measured, C9 and C11 cells showed significantly reduced synthesis of cyclin E and cyclin-dependent kinase (cdk) 4 as well as a decrease in cyclin E-associated cdk activity. These observations led us to conclude that TIS21 overexpression in G1 phase decreased the amounts of cyclin E and cdk4, thereby decreasing the activity of cdks at the G1-S transition.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9766435     DOI: 10.1002/(sici)1098-2744(199809)23:1<25::aid-mc4>3.0.co;2-g

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  26 in total

1.  Molecular characterization, expression pattern and association analysis of the porcine BTG2 gene.

Authors:  X Y Mo; J Lan; Q Z Jiao; Y Z Xiong; B Zuo; F E Li; D Q Xu; M G Lei
Journal:  Mol Biol Rep       Date:  2010-11-30       Impact factor: 2.316

2.  A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation.

Authors:  Alexander D Boiko; Sarah Porteous; Olga V Razorenova; Vadim I Krivokrysenko; Bryan R Williams; Andrei V Gudkov
Journal:  Genes Dev       Date:  2006-01-15       Impact factor: 11.361

3.  BTG2 inhibits the proliferation and metastasis of osteosarcoma cells by suppressing the PI3K/AKT pathway.

Authors:  Yi-Jin Li; Bao-Kang Dong; Meng Fan; Wen-Xue Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-10-01

4.  Btg2 enhances retinoic acid-induced differentiation by modulating histone H4 methylation and acetylation.

Authors:  Daniela Passeri; Antonella Marcucci; Giovanni Rizzo; Monia Billi; Maddalena Panigada; Luca Leonardi; Felice Tirone; Francesco Grignani
Journal:  Mol Cell Biol       Date:  2006-07       Impact factor: 4.272

5.  TIS21/BTG2 inhibits breast cancer growth and progression by differential regulation of mTORc1 and mTORc2-AKT1-NFAT1-PHLPP2 signaling axis.

Authors:  Santhoshkumar Sundaramoorthy; Preethi Devanand; Min Sook Ryu; Kye Yong Song; Dong Young Noh; In Kyoung Lim
Journal:  J Cancer Res Clin Oncol       Date:  2018-05-28       Impact factor: 4.553

6.  Arrest of G(1)-S progression by the p53-inducible gene PC3 is Rb dependent and relies on the inhibition of cyclin D1 transcription.

Authors:  D Guardavaccaro; G Corrente; F Covone; L Micheli; I D'Agnano; G Starace; M Caruso; F Tirone
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

Review 7.  TIS21 (/BTG2/PC3) as a link between ageing and cancer: cell cycle regulator and endogenous cell death molecule.

Authors:  In Kyoung Lim
Journal:  J Cancer Res Clin Oncol       Date:  2006-02-03       Impact factor: 4.553

8.  The BTG2 protein is a general activator of mRNA deadenylation.

Authors:  Fabienne Mauxion; Céline Faux; Bertrand Séraphin
Journal:  EMBO J       Date:  2008-03-13       Impact factor: 11.598

9.  Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation.

Authors:  Toru Suzuki; Junko K-Tsuzuku; Rieko Ajima; Takahisa Nakamura; Yutaka Yoshida; Tadashi Yamamoto
Journal:  Genes Dev       Date:  2002-06-01       Impact factor: 11.361

10.  B cell translocation gene 2 enhances susceptibility of HeLa cells to doxorubicin-induced oxidative damage.

Authors:  Young-Bin Lim; Tae Jun Park; In Kyoung Lim
Journal:  J Biol Chem       Date:  2008-10-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.